What is a key consequence of underrepresentation of women in medical trials?

What is a key consequence of underrepresentation of women in medical trials?

• A. It ensures equal understanding of women's health
• B. It only affects men
• C. Underrepresentation of women in trials can overlook sex-specific symptoms and treatment effects
• D. It has no impact on clinical guidelines

Answer: (C)

Underrepresentation of women in medical trials creates gaps in what we know about how diseases show up in women and how treatments work for them. When women aren’t adequately included, the data used to diagnose, treat, and dose medications may not reflect real-world female patients. This means sex-specific symptoms can be overlooked, drug effectiveness can appear different, and the risk of side effects may differ, all of which can lead to less effective or less safe care for women. Because clinical guidelines are built from trial data, missing or biased information about women translates into guidelines that aren’t as applicable to half the population, making it harder to provide optimal care. In short, the consequence is that sex-specific symptoms and treatment effects can be overlooked, which undermines how well health care serves women.

Underrepresentation of women in medical trials creates gaps in what we know about how diseases show up in women and how treatments work for them. When women aren’t adequately included, the data used to diagnose, treat, and dose medications may not reflect real-world female patients. This means sex-specific symptoms can be overlooked, drug effectiveness can appear different, and the risk of side effects may differ, all of which can lead to less effective or less safe care for women. Because clinical guidelines are built from trial data, missing or biased information about women translates into guidelines that aren’t as applicable to half the population, making it harder to provide optimal care. In short, the consequence is that sex-specific symptoms and treatment effects can be overlooked, which undermines how well health care serves women.